Clinical trial
Correlation Between Regional Brain Volume and Response to Donepezil Treatment in…
NCT00165750 · Eisai Korea Inc., Industry · Terminated
Key facts
| NCT number | NCT00165750 |
|---|---|
| Title | Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients |
| Official title | Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients |
| Lead sponsor | Eisai Korea Inc., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | DONEPEZIL HYDROCHLORIDE |
| Enrollment | 40 |
| Start date | Mar 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 20, 2013 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: